Compare New York Times Co (NYT) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
New York Times Co vs Summit Therapeutics Inc — how do they compare? New York Times Co trades at $75.56 (market cap $12.29B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: New York Times Co is the larger of the two by market cap, and New York Times Co pays a 1.21% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NYT | SMMT | |
|---|---|---|
Market Cap | $12.29B | $10.48B |
Sector | Media | Health |
52-Week High | $85.86 | $29.32 |
52-Week Low | $51.43 | $13.05 |
Enterprise Value | $11.68B | $9.90B |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
